1. Home
  2. OVBC vs CRBP Comparison

OVBC vs CRBP Comparison

Compare OVBC & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$46.86

Market Cap

212.7M

Sector

Finance

ML Signal

N/A

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$11.08

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVBC
CRBP
Founded
1872
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.7M
190.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
OVBC
CRBP
Price
$46.86
$11.08
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$45.50
AVG Volume (30 Days)
26.9K
536.0K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
2.22%
N/A
EPS Growth
42.67
N/A
EPS
1.53
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$116.00
P/E Ratio
$30.73
N/A
Revenue Growth
N/A
97.62
52 Week Low
$34.18
$7.12
52 Week High
$51.25
$20.56

Technical Indicators

Market Signals
Indicator
OVBC
CRBP
Relative Strength Index (RSI) 65.93 67.59
Support Level $46.54 $7.62
Resistance Level $47.12 $11.64
Average True Range (ATR) 1.17 0.62
MACD 0.18 0.07
Stochastic Oscillator 84.96 91.15

Price Performance

Historical Comparison
OVBC
CRBP

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: